Table 3.
Outcomes at baseline vs. end of follow up among participants who enrolled in AMPATH prior to EAT (a pre/post comparison)
| At EAT baseline N = 60 n (%, 95% CI) | At end of EAT follow up N = 60 n (%, 95% CI) | P-Valuea | |
|---|---|---|---|
| Active in care at AMPATH | 44 (73, 62–85) | 53 (88, 80–96) | 0.039 |
| Initiated ART | 56 (93, 87–100) | 60 (100) | 1.000 |
| Had a viral load measurea | 33 (55, 42–68) | 50 (83, 74–93) | < 0.001 |
| Virally suppressed at most recent viral load measurea | 25 (42, 29–54) | 38 (63, 51–76) | 0.012 |
aWithin the 19 months before EAT, for equivalence with duration of EAT follow-up
P-value associated with McNemar’s Chi-square test statistic
Bold values indicate statistical significance